OQROGet OQRO Pro
Politician trade (House)

Vaxcyte (PCVX)Rep. Gilbert Cisneros (CA31) disclosed a purchase $1K–$15K

Rep. Gilbert Cisneros (CA31) disclosed a purchase of Vaxcyte in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
50 days
Disclosure lag
Traded
Jul 16, 2026
Disclosed
Sep 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2026CongressDisclosed purchase of PCVX — reported range $1,001 - $15,000
  2. May 13, 2026CongressDisclosed purchase of PCVX — reported range $1,001 - $15,000
  3. Jun 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 17, 2026, Jacks Lee notified the Board of Directors (the “Board”) of Vaxcyte, Inc. (“the “Company”) of his retirement from the Board, effective as of June 17, 2026.”
  4. Jul 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 13, 2026, Heath Lukatch notified the Board of Directors (the “Board”) of Vaxcyte, Inc. (“the “Company”) of his retirement from the Board, effective as of July 16, 2026.”
  5. Jul 16, 2026 · this disclosureCongressDisclosed purchase of PCVX — reported range $1,001 - $15,000

What came next

  1. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  2. Aug 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On August 31, 2026, Vaxcyte, Inc. (the “Company”) appointed David McAvoy as the Company's Chief Legal Officer, Chief Compliance Officer, and Corporate Secretary.”
  3. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$128K)
  4. Oct 5, 2026Insider · 2 peopleInsiders: 2 sales (~$3.2M)
  5. Oct 6, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Vaxcyte

For Vaxcyte, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 9 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PCVX page.

Other recent filings by Rep. Gilbert Cisneros (CA31)

The full history of Rep. Gilbert Cisneros (CA31) is on the profile page.

How this filing works

Other disclosures at Vaxcyte

Everything OQRO holds on this company is on its PCVX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data